Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Rebound Effect on Stopping Clopidogrel
Link ID 3104
Title Rebound Effect on Stopping Clopidogrel
Url http://www.medscape.com/viewarticle/569917?src=rss
Description An increase in cardiac events after stopping clopidogrel in acute coronary syndrome has led to suggestions that the dose may need to be tapered or the drug to be taken for longer periods. Medscape Medical News
Category Articles > Cardiology
Keywords
Date Feb 9, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Cardiology
1. Obesity Does Not Significantly Affect Survival After Cardiac Transplant
  In a study of 430 patients transplanted during a 10-year period, body mass index (BMI) was not an independent predictor of mortality, and no level of BMI led to significantly worse survival. Medscape Medical News
Category:   Articles > Cardiology


2. AHA Publishes Statement on Integrating Prehospital ECGs Into Care for ACS Patients
  The challenge will not be in acquiring a prehospital electrocardiogram but rather using and integrating the diagnostic information obtained by emergency medical services into existing systems of care. Medscape Medical News
Category:   Articles > Cardiology


3. ABSORBing the Details: 12-Month Results for Bioabsorbable, Everolimus-Eluting Stent
  Experts acknowledge there are hurdles to overcome--particularly in striking the right balance between radial strength and rate of bioabsorption--but they are also increasingly convinced that dissolving stents will be the way of the future. Heartwire
Category:   Articles > Cardiology


4. BEAUTIFUL For Some: No Overall Advantage of Ivabradine, But High-Heart-Rate Patients May Benefit
  Ivabradine was no better than placebo in terms of reducing cardiac death and other coronary and heart-failure outcomes in the overall trial population; however, patients with heart rates higher than 70 bpm had reduced hospitalizations for heart failure and MI and reduced revascularizations with ivabradine. Heartwire
Category:   Articles > Cardiology


5. New Data Look Promising for Rivaroxaban
  Two phase 3 trials with the new oral anticoagulant rivaroxaban suggest it is more effective than enoxaparin in preventing venous thromboembolism in patients undergoing major orthopedic surgery. Heartwire
Category:   Articles > Cardiology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS